426 research outputs found
Biomarkers to personalize the treatment of rheumatoid arthritis: Focus on autoantibodies and pharmacogenetics
Rheumatoid arthritis (RA) is a chronic inflammatory disease that is very complex and heterogeneous. If not adequately treated, RA patients are likely to manifest excess of morbidity and disability with an important impact on the quality of life. Pharmacological treatment is based on the administration of the disease-modifying antirheumatic drugs (DMARDs), subdivided into conventional synthetic (csDMARDs), targeted synthetic (tsDMARDs), and biological (bDMARDs). bDMARDs are now frequently administered in patients, both as alternative treatment and together with csDMARDs. Unfortunately, there is a therapeutic response variability both to old and new drugs. Therefore, to identify pre-therapeutic and on-treatment predictors of response is a priority. This review aims to summarize recent advances in understanding the causes of the variability in treatment response in RA, with particular attention to predictive potential of autoantibodies and DMARD pharmacogenetics. In recent years, several biomarkers have been proposed to personalize the therapy. Unfortunately, a magic bullet does not exist, as many factors concur to disease susceptibility and treatment outcomes, acting around the patient’s congenital background. Models integrating demographic, clinical, biochemical, and genetic data are needed to enhance the predictive capacity of specific factors singularly considered to optimize RA treatment in light of multidisciplinary patient management
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1
Exercise training (ET) is a natural activator of silent mating type information regulation 2 homolog 1 (SIRT1), a stress-sensor able to increase the endogenous antioxidant system. SIRT1 activators include polyphenols and vitamins, the antioxidant properties of which are well-known. Antioxidant supplements are used to improve athletic performance. However, they might blunt ET-related benefits. Middle-distance runners (MDR) taking (MDR-S) or not taking antioxidant supplements (MDR-NoS) were compared with each other and with sedentary subjects (CTR) to evaluate the ET effects on SIRT1 levels and oxidative stress, and to investigate whether an exogenous source of antioxidants could interfere with such effects. Thirty-two MDR and 14 CTR were enrolled. MDR-S took 240 mg vitamin C and 15 mg vitamin E together with mineral salts. SIRT1 mRNA and activity were measured in PBMCs. Total oxidative status (TOS) and total antioxidant capacity (TEAC) were determined in plasma. MDR showed higher levels of SIRT1 mRNA (p = 0.0387) and activity (p = 0.0055) than did CTR. MDR-NoS also showed higher levels than did MDR-S without reaching statistical significance. SIRT1 activity was higher (p = 0.0012) in MDR-NoS (1909 ± 626) than in MDR-S (1276 ± 474). TOS did not differ among the groups, while MDR showed higher TEAC levels than did CTR (2866 ± 581 vs. 2082 ± 560, p = 0.0001) as did MDR-S (2784 ± 643) and MDR-NoS (2919 ± 551) (MDR-S vs. CTR, p = 0.0007 and MDR-NoS vs. CTR, p = 0.003). TEAC (β = 0.4488356, 95% CI 0.2074645 0.6902067; p < 0.0001) and the MDR-NoS group (β = 744.6433, 95% CI 169.9954 1319.291; p= 0.012) predicted SIRT1 activity levels. Antioxidant supplementation seems to hinder the role of ET as a natural activator of SIRT1
Abrupt Convergence and Escape Behavior for Birth and Death Chains
We link two phenomena concerning the asymptotical behavior of stochastic
processes: (i) abrupt convergence or cut-off phenomenon, and (ii) the escape
behavior usually associated to exit from metastability. The former is
characterized by convergence at asymptotically deterministic times, while the
convergence times for the latter are exponentially distributed. We compare and
study both phenomena for discrete-time birth-and-death chains on Z with drift
towards zero. In particular, this includes energy-driven evolutions with energy
functions in the form of a single well. Under suitable drift hypotheses, we
show that there is both an abrupt convergence towards zero and escape behavior
in the other direction. Furthermore, as the evolutions are reversible, the law
of the final escape trajectory coincides with the time reverse of the law of
cut-off paths. Thus, for evolutions defined by one-dimensional energy wells
with sufficiently steep walls, cut-off and escape behavior are related by time
inversion.Comment: 2 figure
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease
OBJECTIVE:
The B cell chemoattractant chemokine ligand 13 (CXCL13) is emerging as a new biochemical marker in RA. This study was undertaken to dissect the relationship between CXCL13 expression levels in the synovium and clinico-pathological variables relevant to RA pathogenesis and outcome.
METHODS:
Synovial tissues from 71 RA patients were evaluated by immunohistochemistry. Thirty paired samples were used for comparative gene expression analysis by quantitative real-time PCR. CXCL13 levels were analysed in relation to cellular, molecular and clinical features of inflammation, lymphocyte activation and joint damage.
RESULTS:
In patients with early disease (<12 months duration), CXCL13 expression correlated significantly with synovial markers of local disease activity and systemic inflammation. Such correlation was less evident in established RA. Notably, the association with lymphocyte infiltration and with expression of B/T cell-related activation and proliferation genes, such as activation-induced cytidine deaminase, IFN-\u3b3 and IL-2, remained highly significant independent of disease duration and local disease activity. Patients featuring the highest levels of CXCL13 were more frequently ACPA positive and IgG ACPA titres were increased in the high CXCL13 expression group. Furthermore, the frequency of erosive disease on radiographs was significantly higher in the upper tertile of CXCL13 expression (P = 0.01 with adjustment for disease duration and ACPA). Accordingly, synovial CXCL13 and the local receptor activator of nuclear factor \u3baB ligand (RANKL)/osteoprotegerin (OPG) ratio significantly co-varied (\u3c1 = 0.52, P < 0.01), independent of the level of local inflammation.
CONCLUSION:
Synovial CXCL13 appears to be a marker of a more severe pattern of RA disease, characterized by increased lymphocyte activation and bone remodelling beyond the level of conventional markers of inflammation
Priming by Chemokines Restricts Lateral Mobility of the Adhesion Receptor LFA-1 and Restores Adhesion to ICAM-1 Nano-Aggregates on Human Mature Dendritic Cells
LFA-1 is a leukocyte specific β2 integrin that plays a major role in regulating adhesion and migration of different immune cells. Recent data suggest that LFA-1 on mature dendritic cells (mDCs) may function as a chemokine-inducible anchor during homing of DCs through the afferent lymphatics into the lymph nodes, by transiently switching its molecular conformational state. However, the role of LFA-1 mobility in this process is not yet known, despite that the importance of lateral organization and dynamics for LFA-1-mediated adhesion regulation is broadly recognized. Using single particle tracking approaches we here show that LFA-1 exhibits higher mobility on resting mDCs compared to monocytes. Lymphoid chemokine CCL21 stimulation of the LFA-1 high affinity state on mDCs, led to a significant reduction of mobility and an increase on the fraction of stationary receptors, consistent with re-activation of the receptor. Addition of soluble monomeric ICAM-1 in the presence of CCL21 did not alter the diffusion profile of LFA-1 while soluble ICAM-1 nano-aggregates in the presence of CCL21 further reduced LFA-1 mobility and readily bound to the receptor. Overall, our results emphasize the importance of LFA-1 lateral mobility across the membrane on the regulation of integrin activation and its function as adhesion receptor. Importantly, our data show that chemokines alone are not sufficient to trigger the high affinity state of the integrin based on the strict definition that affinity refers to the adhesion capacity of a single receptor to its ligand in solution. Instead our data indicate that nanoclustering of the receptor, induced by multi-ligand binding, is required to maintain stable cell adhesion once LFA-1 high affinity state is transiently triggered by inside-out signals.Peer ReviewedPostprint (published version
Orthostatic hypotension, an often-neglected problem in community-dwelling older people: discrepancies between studies and real life
First-Principles Study of the Electronic and Magnetic Properties of Defects in Carbon Nanostructures
Understanding the magnetic properties of graphenic nanostructures is
instrumental in future spintronics applications. These magnetic properties are
known to depend crucially on the presence of defects. Here we review our recent
theoretical studies using density functional calculations on two types of
defects in carbon nanostructures: Substitutional doping with transition metals,
and sp-type defects created by covalent functionalization with organic and
inorganic molecules. We focus on such defects because they can be used to
create and control magnetism in graphene-based materials. Our main results are
summarized as follows: i)Substitutional metal impurities are fully understood
using a model based on the hybridization between the states of the metal
atom and the defect levels associated with an unreconstructed D carbon
vacancy. We identify three different regimes, associated with the occupation of
distinct hybridization levels, which determine the magnetic properties obtained
with this type of doping; ii) A spin moment of 1.0 is always induced by
chemical functionalization when a molecule chemisorbs on a graphene layer via a
single C-C (or other weakly polar) covalent bond. The magnetic coupling between
adsorbates shows a key dependence on the sublattice adsorption site. This
effect is similar to that of H adsorption, however, with universal character;
iii) The spin moment of substitutional metal impurities can be controlled using
strain. In particular, we show that although Ni substitutionals are
non-magnetic in flat and unstrained graphene, the magnetism of these defects
can be activated by applying either uniaxial strain or curvature to the
graphene layer. All these results provide key information about formation and
control of defect-induced magnetism in graphene and related materials.Comment: 40 pages, 17 Figures, 62 References; Chapter 2 in Topological
Modelling of Nanostructures and Extended Systems (2013) - Springer, edited by
A. R. Ashrafi, F. Cataldo, A. Iranmanesh, and O. Or
Molecule-by-Molecule Writing Using a Focused Electron Beam
The resolution of lithography techniques needs to be extended beyond their current limits to continue the trend of miniaturization and enable new applications. But what is the ultimate spatial resolution? It is known that single atoms can be imaged with a highly focused electron beam. Can single atoms also be written with an electron beam? We verify this with focused electron-beam-induced deposition (FEBID), a direct-write technique that has the current record for the smallest feature written by (electron) optical lithography. We show that the deposition of an organometallic precursor on graphene can be followed molecule-by-molecule with FEBID. The results show that mechanisms that are inherent to the process inhibit a further increase in control over the process. Hence, our results present the resolution limit of (electron) optical lithography techniques. The writing of isolated, subnanometer features with nanometer precision can be used, for instance, for the local modification of graphene and for catalysis.</p
- …